Clinical Trials in Italy / NCT07644936
Starting soon Observational

Molecular Characterization of Autoimmune Hepatitis: A Lipidomic Approach

NCT07644936 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2026-07-01
Last updated
2026-07-15

Condition(s) studied

Autoimmune HepatitisNon-Alcoholic Fatty Liver Disease

Study summary

This is a two-arm, prospective, controlled observational pilot clinical study aimed at characterizing the lipidomic profile and extracellular vesicles (EVs) of patients with autoimmune hepatitis (AIH) compared to patients with non-alcoholic fatty liver disease (NAFLD). A total of 24 adult outpatients will be enrolled at the Hepatology Outpatient Unit of IRCCS "S. de Bellis". Blood samples will be collected by venipuncture to perform lipidomic analyses on red blood cell membranes and serum, and to isolate and characterize EVs. No intervention beyond standard clinical practice will be applied

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: ARM A: * Confirmed diagnosis of autoimmune hepatitis (AIH); * Adult age (≥18 years); * Ability to provide written informed consent; Attending the Hepatology Outpatient Unit of IRCCS "S. de Bellis" ARM B: Exclusion Criteria: * Confirmed diagnosis of non-alcoholic fatty liver disease (NAFLD); * Adult age (≥18 years); * Ability to provide written informed consent; Attending the Hepatology Outpatient Unit of IRCCS "S. de Bellis" Esclusion Criteria: * Liver cirrhosis; * Active oncological diseases; * Viral hepatitis (HBV, HCV, HIV infection); * Severe medical conditions that may compromise study participation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
IRCCS "S. de Bellis" - Nutritional Biochemistry Lab Castellana Grotte Bari

More Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07644936 on ClinicalTrials.gov ↗ ← All trials in Italy